MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook for Successful Drug Launches

At the MAPS Americas 2025 conference in New Orleans, one of the pivotal discussions centered around preparing for drug launches in the current pharmaceutical landscape. While many important topics were covered, a critical element that was notably missing from the discussion was the need for a strategic north star—a guiding philosophy that ensures all tactical…...
Read More

Top Stories

DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...

A Guide to Creating a Robust Patient Engagement Strategy

Get started on effective patient engagement in your pharmaceutical or biotech company with our comprehensive...

Launch Excellence: The Path Forward for Medical Affairs

Learn how Medical Affairs can redefine launch excellence by streamlining the journey from clinical trial...

Diversity, Equity, and Inclusion: The Fuel That Drives Business Forward

Ensuring that your organization embraces DE & I training is important for cultivating a strong...
people-forming-a-chain

Why Is It Important to Include Patients as Peer Reviewers

Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are...
Medical Device Regulation

Clinical Evidence: How Much Is Enough?

Ensuring the safety and functionality of your medical device is vital. But how much clinical...
a-man-questioning-medical-device-regulatory-options

Which Regulatory Requirements Are Applicable to “Legacy” Devices?

Understanding the requirements for your medical device is vital in today’s market. But are these...

Learn more ABOUT our company.